News About: Pharm. Industry
My humanitarian aid in Armenia
My experience in Medecins Sans Frontieres (MSF), or Doctors Without Borders, was quite unforgettable, said Bang ji-woon, Gilead Associate
During an interview, he said MSF provided an opportunity to increase a close...
Government to cut drug prices of 20 drug makers
Now that 20 pharmaceutical firms were caught offering kickbacks to doctors, the price paid for the drug will be lowered by up to 20 percent.
In August of 2010, the Ministry of Health and Welfare introduced a rule w...
Local drug makers to fare worse this year
The outlook for Korean pharmaceutical companies’ earnings is taking a turn for the worse this year as the government has been investigating companies offering illegal rebates to hospitals and doctors.
The governmen...
84 doctors caught taking rebate
Eighty-four doctors from 97 hospitals taking rebates between December 2010 and July 2011 received administrative measure, according to the prosecution.
They accepted the rebates from a mid-sized drug firm in return...
Court rules fine over ‘pay for delay’ to GSK is justifiable
An appeals court ruled Thursday that fines of 3.1 billion won was justifiable over “pay for delay” the Fair Trade Commission (FTC) imposed to GlaxoSmithKline (GSK).
Turning down an appeal from GSK, the Seoul High C...
Celltrion to cut Remsima price by 50% for low-income households
Celltrion, a local biopharmaceutical company, said it will cut the insurance price of its antibody biosimilar product “Resima” by 50 percent for low-income patients who are not covered by the national health insurance...
Leading pharmaceutical firms continue to add subsidiariesThe business expansion of Korea’s major drug firms shows no sign of abating, with the number of their affiliated companies averaging 10, according to a report by Yakup.com, phar...
|
Green Cross making all-out efforts for management normalization of Innocell
Green Cross Corp., the largest shareholder of Innocell, a cell therapeutics company, said in its regulatory filing Wednesday that it has decided to voluntarily restrict the selling of its equities over the next three ...
Yooyoung launches new combination form to treat dyslipidemias
Yooyoung Pharmaceutical said yesterday it has recently launched Pravafenix, SMB’s fixed dose combination drug to treat dyslipidemias, with an exclusive marketing right here.
Approved by the European Commission in A...
Jeil rekindling strategic alliance flame
Jeil Pharmaceutical is actively seeking strategic alliances with a number of multinational pharmaceutical firms using its strong sales and marketing force.
Jeil said Monday that it has agreed with Lundbeck Korea t...
